Will Cannabis Genetics Be Restricted?
A redefinition of hemp under federal law, set to take place Nov. 12, signals the end of Farm Bill safeguards for numerous hemp-derived THC products across the nation: low-dose beverages as well as THCA flower and delta-8 THC edibles, vapes and other products sold at gas stops and smoke shops.
But the hemp ban also creates a major complication for the legitimate cannabis sector. Seeds from cannabis cultivars that produce flower with greater than 0.3% THC are no longer legal to transport out of state.
Although seed buying will probably continue in legal states, the modifications threaten to shutter some seed suppliers and genetics businesses, observers say, while creating supply-chain problems for cannabis cultivators and retailers.
“If this language goes through, we will require pop-up shops to sell seeds in every state where it’s permitted,” Campanella said. “Which is why we’re also offering clones and tissue culture, because that’s not covered in the bill.”
When are cannabis seeds and clones prohibited to ship between state lines?
The new regulations classify seeds based on the THC potential of the mother plant. Genetic substances such as seeds and clones are made illegal if the final product exceeds the threshold.
For the moment, seeds are still shipping under the 2018 Farm Bill’s current quo. But the clock is ticking for enterprises like Brothers Grimm and for cannabis cultivators who worry about supply chain interruptions if out-of-state access to genetics is prohibited.
Most of the cannabis industry remains largely unaware of the approaching shutdown of the interstate genetics market, said Ryan Power, co-founder of Sebastopol, California-based company Atlas Seed.
Without government intervention in the way of an exception for seeds or a general moratorium, numerous seed providers will just be shuttered by November, he added.
“We are operating legally currently, but if that shifts, it will upend the legal licensed sector in each state,” said Power, whose customers includes seed banks as well as licensed business cultivators.
“Consumers are going to forfeit choice, and it will be a major shutdown for most people.”
What are cannabis seed suppliers doing to remain legal after the federal hemp ban?
Sagui Silber has previously recalibrated Silberhaze Genetics, https://nativesusa.com/ (https://nativesusa.com/) his Ohio genetics business, because of state Senate Bill 56, which tightened cannabis oversight in that state while also restricting hemp-derived THC products to licensed cannabis retailers.
Formerly a seed bank, Silberhaze is currently focused on the branding, preservation and IP safeguarding of elite plant genetics.
That’s because seed companies hoping to stay compliant in this new environment must have solid documentation, he said.
“You have to prove where this material comes from, so it’s very important to have records, even to the extent where you have cultivator names,” Silber said.
“Small businesses will have to operate with better records and a stronger chain of possession,” he added. “We need that documentation too, because we don’t want to be working with questionable sources.”
To prevent seizures and other legal fallout, seed entrepreneurs must “get their affairs in order” before the new regulations take effect, Silber said.
“Audit all your stuff immediately, and categorize what you can,” Silber said. “Take inventory, document your lineage, preserve cultivator records, and arrange any cannabinoid or terpene data you currently have. If regulations change, you’ll be in a much better position to understand what may be affected and make informed decisions.”
Does federal marijuana rescheduling impact cannabis genetics?
Silber believes U.S. Drug Enforcement Administration licensing may be required for companies engaged in research.
But for now, seed houses can’t enroll with the DEA like state-licensed therapeutic cannabis operators can. Such an option is not available to seed banks, nurseries or genetics businesses, said Jim Ickes, a lawyer and partner with Frantz Ward’s cannabis practice group in Cleveland.
“Genetics activity may be happening inside larger state-licensed therapeutic marijuana operations, as some states allow dispensaries or registered medical operators to sell seeds, clones or home-cultivation materials,” he said.
“But that is distinct from the DEA creating a freestanding seed supplier registration category.”
Some genetics companies are already changing operational practices to comply with the updated law. According to Ickes, they must answer questions including:
- Which of our lines produce plants above 0.3% total THC?
- Which seeds remain as hemp after Nov. 12, 2026, and which don’t?
- What does our inventory look like once we organize it against the genetics exclusion?
Ickes also understands confusion from customers who believed federal rescheduling of medical marijuana would clarify their situation with financial institutions. However, the recent regulatory language has moved those conversations beyond the fundamentals of classification, he said.
“Financial institutions ask whether this specific revenue source is legal, whether it connects to state-licensed activity, or whether there’s cross-state risk,” said Ickes.
“After November, a seed bank selling drug-type genetics can’t address the first question with the hemp definition. It has to refer to a legal state cannabis channel instead. Seed banks dealing in authentic industrial-hemp seed keep the cleaner story.”
What’s the future of cannabis genetics?
Campanella is part of a emerging coalition of fellow breeders, farmers and researchers that’s arguing seeds are more appropriately defined as agricultural inputs than controlled substances. To that end, seeds should be overseen by the U.S. Department of Agriculture, allowing the DEA to focus its enforcement efforts elsewhere.
“How do you regulate something based on what it could become one day?” said Campanella. “Our choice is to have that language removed, or have seeds regulated by the USDA as a hemp product.”
But in the meantime, Campanella is reorganizing Brothers Grimm to function outside the scope of shifting federal oversight. The business plans to keep its Colorado seed facility while positioning its Oklahoma tissue culture facility as a safeguard against government prohibition of cannabis seeds.
As she noted: “If things evolve in a way where we can’t focus on interstate transport, we’ll have additional resources to meet people’s requirements without getting ourselves in trouble.”
